Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker

Cerebrospinal fluid and positron emission tomography biomarkers accurately predict an underlying Alzheimer's disease (AD) pathology; however, they represent either invasive or expensive diagnostic tools. Therefore, a blood-based biomarker like plasma amyloid beta (Aβ) that could correlate with...

Descripción completa

Detalles Bibliográficos
Autores principales: Toledo, Jon B, Shaw, Leslie M, Trojanowski, John Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706955/
https://www.ncbi.nlm.nih.gov/pubmed/23470128
http://dx.doi.org/10.1186/alzrt162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706955/
https://www.ncbi.nlm.nih.gov/pubmed/23470128
http://dx.doi.org/10.1186/alzrt162

Ejemplares similares